GLP-1-based treatment of diabetes does not cause pancreatitis

(University of Copenhagen The Faculty of Health and Medical Sciences) The commonly used treatment for type 2 diabetes and obesity, GLP-1, does not cause pancreatitis. The treatment is known to increase two markers of pancreatitis, but now, a new study shows a harmless, physiological explanation. The finding from the University of Copenhagen can contribute to the safety of diabetes treatment on a global scale.